NSEAction(s) taken or orders passed3d ago · 6 Nov 2026, 04:25 pm
Action(s) taken or orders passed
Dabur India Limited · DABUR
✦ AI Summary▼ NegativeRegulatory
Dabur India Limited has received an administrative warning letter from SEBI for delay in making disclosure of a warning letter received from US FDA under Regulation 30 of SEBI Listing Regulations. The company has been warned to be careful in future to avoid recurrence of such lapses.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern8/10
Regulatory Risk9/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment4/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dabur India Limited has informed the Exchange about Administrative warning letter received from SEBI
Attachments (1)
📄pdf
Download →
DABURA_06112026162506_Letter.pdf
View document text
Ref: SEC/SE/2026-27
Date: November 06, 2026
Corporate Relations Department Listing Department
BSE Ltd. National Stock Exchange of India Ltd.
Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor
Dalal Street, Plot No. C/1, G Block Bandra – Kurla Complex
Mumbai- 400001 Bandra (E), Mumbai – 400051
BSE Scrip Code: 500096 NSE Scrip Symbol: DABUR
Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“SEBI Listing Regulations”)
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI Listing Regulations, please note that Securities and Exchange
Board of India (SEBI) has issued an administrative warning letter to the Company alleging violation
with provisions of Regulation 30 read with sub-para 20 of Para A Part A Schedule II of SEBI Listing
Regulations.
Requisite information as per Regulation 30 of SEBI Listing Regulations along with letter issued by
SEBI to the Company, is annexed as Annexure 1 and 2 respectively.
It is submitted that the Company has always been the most compliant in following all the SEBI Listing
Regulations. The Company will take necessary steps to address the concern/directive mentioned in
the aforesaid letter.
Request you to kindly take the above information on records.
The above intimation is also available on the website of the Company at www.dabur.com.
Thanking You,
Yours faithfully,
For Dabur India Limited
(Ashok Kumar Jain)
Group Company Secretary and Chief Compliance Officer
DABUR INDIA LIMITED, Punjabi Bhawan, 10, Rouse Avenue, New Delhi – 110 002, Tel.: +91 11 71206000
Regd. Office: 8/3, Asaf Ali Road, New Delhi – 110 002 (India)
CIN: L24230DL1975PLC007908, Email: corpcomm@dabur.com Website: www.dabur.com
Annexure 1
Following details pertaining to the actions(s) initiated, taken or orders passed by any regulatory,
statutory, enforcement authority or judicial body are required to be informed to Stock Exchanges
1 Name of the authority Securities and Exchange Board of India
(“SEBI”)
2 Nature and details of the action(s) Administrative warning and advice letter
taken, initiated or order(s) passed received from SEBI by the Company, to be
careful in future to avoid recurrence of such
lapses i.e. delay in disclosure.
3 Date of receipt of direction or order, Received vide email dated 06.11.2026 at
including any ad-interim or interim 12.40 p.m.
orders, or any other communication
from the authority
4 Details of the The said warning letter alleges violation of
violation(s)/contravention(s) Regulation 30(6)(iii) of SEBI (Listing
committed or alleged to be Obligations and Disclosure Requirement)
committed Regulations, 2015 (“SEBI (LODR)
Regulations”) on account of delay in making
disclosure of warning letter received from US
FDA on July 24, 2026 under Regulation 30
read with sub-para 20 of Para A of Part A of
Schedule III of SEBI (LODR) Regulations.
5 Impact on financial, operation or There is no impact on the financial operations
other activities of the listed entity, and other activities of the company due to
quantifiable in monetary terms to aforesaid administrative warning letter issued
the extent possible by SEBI.
DABUR INDIA LIMITED, Punjabi Bhawan, 10, Rouse Avenue, New Delhi – 110 002, Tel.: +91 11 71206000
Regd. Office: 8/3, Asaf Ali Road, New Delhi – 110 002 (India)
CIN: L24230DL1975PLC007908, Email: corpcomm@dabur.com Website: www.dabur.com
Annexure-2
s~31 ~ttftlf vftt~ftt Jft1 fctf.tlrlf ifrt
Securities and Exchange Board of India
'3)q JOI ti I Q< Si trCP"
DEPUTY GENERAL MANAGER
frf Tfl1 fcnf ftf 'l-f11T
CORPORATION FINANCE DEPARTMENT
°Q1f<l afUT, "QCRf;:r ~ ~Ct> I lkfl' ~-af ctft "W"'l-fl1T - 5
DIVISION OF SUPERVISION, ENFORCEMENT AND COMPLAINTS - 5
1125185/2026
November 06, 2026
Dabur India Limited,
8/3, Asaf Ali Road, New Delhi,
Delhi - 110002.
Sir,
Kind Attention: Mr. Ashok Kumar Jain, Company Secretary and Chief
Compliance Officer
Sub: Administrative Warning - Violation of provisions of SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, ("LODR
Regulations") in the matter of Dabur India Limited
1. This is reference to the examination conducted by SEBI in the matter of Dabur India
Limited. In this regard, it is obseived that the Dabur India Limited is in violation of
following:
a) Delay in making disclosure of information i.e Warning letter issued by USFDA
on July 24, 2026 under Regulation 30 read with sub-para 20 of Para A Part A
Schedule Ill of SEBI (LODR), Regulations.
2. The above non-compliances has been viewed seriously. Accordingly, the company
and its Board of Directors are hereby warned and advised to be careful in future to
avoid recurrences of such lapses. Any repetition of the such violation in future will
be viewed seriously and appropriate enforcement action would be initiated in
accordance with the provisions of the SEBI Act, 1992, the Rules, the Regulations
or Circulars issued thereunder.
3. You are also advised to place this communication before your board of directors in
the upcoming board meeting and forward their comments to SEBI, as to whether
~· - they are satisfied with the corrective steps taken in ensuring future compliance.
Mm, '"1ft" ~ ~-WM'f Cf51A{T)Cff1, ~ - ~oo o<.~
SEBI Bhavan, UG" Block, Bandra Kurla Complex, Mumbai - 400 051
www.sebi.gov.in 022 - 2644 9000 / 4045 9000
-mttfttr llfct'{fct aitl fctf.tirlJ illt
Securities and Exchange Board of India Continuation:
4. You are also advised, to disclose the instant administrative warning letter to the
stock exchange under Regulation 30 of the SEBI (LODR) Regulations, 2015.
Yours faithfully,
"The issuance of this document may be verified on the web-page accessible through
the QR code printed here or from the link - https:llwww.sebi.gov.in/sebiweb/dnvs
authentication-v2.html."